Search by Drug Name or NDC

    NDC 61919-0371-20 CIPROFLOXACIN 250 mg/1 Details

    CIPROFLOXACIN 250 mg/1

    CIPROFLOXACIN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is CIPROFLOXACIN HYDROCHLORIDE.

    Product Information

    NDC 61919-0371
    Product ID 61919-371_f9b3a0ce-ac23-7eb0-e053-6394a90ab4ae
    Associated GPIs 05000020100310
    GCN Sequence Number 009509
    GCN Sequence Number Description ciprofloxacin HCl TABLET 250 MG ORAL
    HIC3 W1Q
    HIC3 Description QUINOLONE ANTIBIOTICS
    GCN 47050
    HICL Sequence Number 004124
    HICL Sequence Number Description CIPROFLOXACIN HCL
    Brand/Generic Generic
    Proprietary Name CIPROFLOXACIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name CIPROFLOXACIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name CIPROFLOXACIN HYDROCHLORIDE
    Labeler Name Direct_Rx
    Pharmaceutical Class Quinolone Antimicrobial [EPC], Quinolones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076639
    Listing Certified Through 2024-12-31

    Package

    NDC 61919-0371-20 (61919037120)

    NDC Package Code 61919-371-20
    Billing NDC 61919037120
    Package 20 TABLET in 1 BOTTLE (61919-371-20)
    Marketing Start Date 2022-09-27
    NDC Exclude Flag N
    Pricing Information N/A